A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design

被引：0
|
作者：
Praveen J Patel
Catey Bunce
Adnan Tufail
机构：
[1] Moorfields Eye Hospital,
来源：
Trials | / 9卷
关键词：
Visual Acuity; Bevacizumab; Optical Coherence Tomography; Ranibizumab; Well Correct Visual Acuity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design
    Patel, Praveen J.
    Bunce, Catey
    Tufail, Adnan
    TRIALS, 2008, 9 (1)
  • [2] Additional Outcomes From the ABC Trial - A Double-Masked, Randomised Controlled Trial of Avastin® (Bevacizumab) Intravitreal Injections for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Age-Related Macular Degeneration (AMD)
    Patel, P. J.
    Xing, W.
    Bunce, C.
    Tufail, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [3] Correlation Between Visual Acuity and Duration of Symptoms in the ABC Trial - A Double-Masked, Randomised Controlled Trial of Intravitreal Avastin (Bevacizumab) Injections for the Treatment of Choroidal Neovascularization (CNV) in Age-Related Macular Degeneration (AMD)
    Esposti, S. Degli
    Patel, P. J.
    Tufail, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [4] Photodynamic therapy combined with intravitreal bevacizumab (avastin) in treatment of choroidal neovascularization secondary to age-related macular degeneration
    Lazic, Ratimir
    Gabric, Nikica
    Dekaris, Iva
    Gavric, Morena
    Bosnar, Damir
    COLLEGIUM ANTROPOLOGICUM, 2007, 31 : 71 - 75
  • [5] Bevacizumab for neovascular age-related macular degeneration (ABC trial): multicenter randomized double-masked study
    Ghazi, Nicola G.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2010, 3 (06) : 747 - 752
  • [6] Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial
    Subramanian, M. L.
    Abedi, G.
    Ness, S.
    Ahmed, E.
    Fenberg, M.
    Daly, M. K.
    Houranieh, A.
    Feinberg, E. B.
    EYE, 2010, 24 (11) : 1708 - 1715
  • [7] Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial
    M L Subramanian
    G Abedi
    S Ness
    E Ahmed
    M Fenberg
    M K Daly
    A Houranieh
    E B Feinberg
    Eye, 2010, 24 : 1708 - 1715
  • [8] Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study)
    Rogério A. Costa
    Rodrigo Jorge
    Daniela Calucci
    Luiz A. S. Melo
    José A. Cardillo
    Ingrid U. Scott
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245 : 1273 - 1280
  • [9] Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study)
    Costa, Rogerio A.
    Jorge, Rodrigo
    Calucci, Daniela
    Melo, Luiz A. S., Jr.
    Cardillo, Jose A.
    Scott, Ingrid U.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (09) : 1273 - 1280
  • [10] Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
    Subramanian, Manju L.
    Ness, Steven
    Abedi, Gelareh
    Ahmed, Ednan
    Daly, Mary
    Feinberg, Edward
    Bhatia, Sumit
    Patel, Payal
    Nguyen, Maileah
    Houranieh, Antoun
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 148 (06) : 875 - 882
12345